Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues
Revenues	$ 29,838	$ 22,585
Other Expense, Net
Unrealized and realized appreciation in fair value of equity securities and preferred stock, net	(106)	70
Equity in net loss of affiliates	(389)	(1,640)
Loss from continuing operations before income taxes	(29,902)	(52,913)
Loss from discontinued operations, net of income taxes	(26,056)	(9,236)
Net loss	(55,998)	(62,136)
Net loss attributable to the noncontrolling interests	0	1,427
Net loss attributable to Precigen	(55,998)	(60,709)
Amounts Attributable to Precigen
Net loss from continuing operations attributable to Precigen	(29,942)	(51,473)
Net loss from discontinued operations attributable to Precigen	(26,056)	(9,236)
Net loss attributable to Precigen	$ (55,998)	$ (60,709)
Net Loss per Share
Net loss from continuing operations attributable to Precigen per share, basic and diluted (in dollars per share)	$ (0.19)	$ (0.34)
Net loss from discontinued operations attributable to Precigen per share, basic and diluted (in dollars per share)	(0.16)	(0.06)
Net loss attributable to Precigen per share, basic and diluted (in dollars per share)	$ (0.35)	$ (0.40)
Weighted average shares outstanding, basic and diluted (in shares)	160,338,743	152,948,058
Collaboration and licensing agreements
Revenues
Revenues	$ 10,721	$ 5,971
Continuing Operations
Revenues
Revenues	29,838	22,585
Operating Expenses
Research and development	18,891	26,938
Selling, general and administrative	23,018	31,049
Total operating expenses	55,534	72,801
Operating loss	(25,696)	(50,216)
Other Expense, Net
Unrealized and realized appreciation in fair value of equity securities and preferred stock, net	0	449
Interest expense	(4,592)	(4,305)
Interest and dividend income	673	1,361
Other income, net	64	546
Total other expense, net	(3,855)	(1,949)
Equity in net loss of affiliates	(351)	(748)
Loss from continuing operations before income taxes	(29,902)	(52,913)
Income tax benefit (expense)	(40)	13
Loss from continuing operations	(29,942)	(52,900)
Continuing Operations | Collaboration and licensing agreements
Revenues
Revenues	10,721	5,971
Continuing Operations | Products
Revenues
Revenues	4,961	4,837
Operating Expenses
Cost of products and services	6,089	7,722
Continuing Operations | Services
Revenues
Revenues	13,946	11,383
Operating Expenses
Cost of products and services	7,536	7,092
Continuing Operations | Other
Revenues
Revenues	$ 210	$ 394